| Bioactivity | Anticancer agent 236 (compound JP-8g) is a broad-spectrum anticancer agent that has toxic effects on several cancer cell lines with IC50 values of 6.925 μM (MDA), 6.296 μM (U937), 6.548 μM (Jurkat), 6.373 μM (Hela), and 10.381 μM (EJ)[1]. |
| CAS | 1356340-69-6 |
| Formula | C27H17F2N3O6 |
| Molar Mass | 517.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jiang X, et al. Core scaffold‐inspired concise synthesis of chiral spirooxindole‐pyranopyrimidines with broad‐spectrum anticancer potency[J]. Advanced Synthesis & Catalysis, 2012, 354(5): 917-925. |
Anticancer agent 236
CAS: 1356340-69-6 F: C27H17F2N3O6 W: 517.44
Anticancer agent 236 (compound JP-8g) is a broad-spectrum anticancer agent that has toxic effects on several cancer cell
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.